Sectors

Cipla signs licensing agreement with Multi G

Cipla Limited on Wednesday announced that it has signed a licensing agreement with Belgium-based firm, Multi G for the distribution of their COVID-19 Rapid Antibody test kit, across Emerging markets and Europe.

After halting clinical trials, Brazil to receive first dose of China’s Sinovac vaccine this week

Maruti Suzuki launches 5th edition of MAIL initiative for start-ups

Rural India’s internet usage drastically increased amid COVID-19 lockdown, surpassing urban areas

Pfizer to start its ‘first ever COVID-19 vaccine delivery program’ in four US states

Bharat Biotech to commence Phase 3 trail of COVAXIN with 26,0000 participants

Moderna reports preliminary trial data: COVID-19 vaccine is more than 94% effective

Vodafone Idea (Vi) likely to hike tariff rates by 20%

State-owned construction firm, NBCC, bags orders worth Rs 1,165 crore in October

Maruti Suzuki posts over 2 lakh cars sale influenced by digital dealerships

AERA likely to lose hold over tariff regulation, post privatisation by Civil Aviation Ministry

COVID-19 Vaccine: First batch of Russian candidate Sputnik-V to reach Kanpur for Phase 2 & 3 trials

. College principal R B Kamal confirmed that the human clinical trials of the vaccine begin next week.

Real estate giant Prestige Group’s sale rose 9% in Q2, despite slowdown in market

Are people scared of using the COVID-19 vaccine?

India to get 100 million shots of AstraZeneca COVID-19 vaccine ‘AZD1222’ by next month

WHO announces plans to set up traditional medicine centres in India